Ht-Logo-gigapixel-icon
Search
Close this search box.
Ht-Logo-gigapixel-icon
Search
Close this search box.
Saturday, November 2, 2024
Canada’s Politics and Government News Source Since 1989
Latest Paper
Saturday, November 2, 2024 | Latest Paper
Subscribe Now

TRENDING:

Colleen Fuller

A national pharmacare plan should cover what’s best for patients, not what’s new

  • Using insulin is always challenging, so access to a broad range of appropriate options is vital.
Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
Coverage should be based on the best and most independent evidence available or we risk throwing money away on drugs and devices that are neither cost-effective nor providing patients with better health outcomes, write Colleen Fuller and Sharon Batt. Unsplash photograph by Towfiqu Barbhuiya

A national pharmacare plan should cover what’s best for patients, not what’s new

Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
  • Using insulin is always challenging, so access to a broad range of appropriate options is vital.

A national pharmacare plan should cover what’s best for patients, not what’s new

Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
  • Using insulin is always challenging, so access to a broad range of appropriate options is vital.
Coverage should be based on the best and most independent evidence available or we risk throwing money away on drugs and devices that are neither cost-effective nor providing patients with better health outcomes, write Colleen Fuller and Sharon Batt. Unsplash photograph by Towfiqu Barbhuiya

A national pharmacare plan should cover what’s best for patients, not what’s new

  • Using insulin is always challenging, so access to a broad range of appropriate options is vital.
Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
Coverage should be based on the best and most independent evidence available or we risk throwing money away on drugs and devices that are neither cost-effective nor providing patients with better health outcomes, write Colleen Fuller and Sharon Batt. Unsplash photograph by Towfiqu Barbhuiya

A national pharmacare plan should cover what’s best for patients, not what’s new

Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
  • Using insulin is always challenging, so access to a broad range of appropriate options is vital.

A national pharmacare plan should cover what’s best for patients, not what’s new

Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
  • Using insulin is always challenging, so access to a broad range of appropriate options is vital.
Coverage should be based on the best and most independent evidence available or we risk throwing money away on drugs and devices that are neither cost-effective nor providing patients with better health outcomes, write Colleen Fuller and Sharon Batt. Unsplash photograph by Towfiqu Barbhuiya
More Stories

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Advertise

get help

Subscribe
CloseMenu